2-Cyclohexyl-N-(3-{1-perhydro-2H-pyran-2-yl-5-[1-(triphenylmethyl)(1,2,4-triazol-3-yl)](1H-indazol-3-yl)}phenyl)acetamide → N-[3-(5-(1H-1,2,4-Triazol-3-YL)(1H-indazol-3-YL))phenyl]-2-cyclohexylacetamide
Reaktionsgleichung
[CH:1]1([CH2:7][C:8]([NH:10][C:11]2[CH:16]=[CH:15][CH:14]=[C:13]([C:17]3[C:25]4[C:20](=[CH:21][CH:22]=[C:23]([C:26]5[N:30]=[CH:29][N:28](C(C6C=CC=CC=6)(C6C=CC=CC=6)C6C=CC=CC=6)[N:27]=5)[CH:24]=4)[N:19](C4CCCCO4)[N:18]=3)[CH:12]=2)=[O:9])[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1>Cl.O1CCOCC1>[NH:28]1[CH:29]=[N:30][C:26]([C:23]2[CH:24]=[C:25]3[C:20](=[CH:21][CH:22]=2)[NH:19][N:18]=[C:17]3[C:13]2[CH:12]=[C:11]([NH:10][C:8](=[O:9])[CH2:7][CH:1]3[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6]3)[CH:16]=[CH:15][CH:14]=2)=[N:27]1Komponenten
4
Edukt 1
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 2
Versuchsvorschrift
2-Cyclohexyl-N-(3-{1-perhydro-2H-pyran-2-yl-5-[1-(triphenylmethyl)(1,2,4-triazol-3-yl)](1H-indazol-3-yl)}phenyl)acetamide was dissolved in 4 mL of 4.0 N HCl in 1,4-dioxane and the reaction was stirred at room temperature overnight. After neutralization with aqueous NaHCO3, the crude product was extracted in ethyl acetate and purified by preparative HPLC (0.034 g, 34% yield over 2 steps): 1H NMR (CD3OD) δ 8.75 (s, 1H), 8.38 (br s, 2H), 8.20 (s, 1H), 8.10 (d, 1H), 7.76 (td, 2H), 7.70 (d, 1H), 7.51 (t, 1H), 2.30 (d, 2H), 1.90 (m, 1H), 1.78 (m, 4H), 1.3 (m, 4H), 1.07 (m, 2H); ES-MS (m/z) 401 [M+H]+.
Aufarbeitung
- extractionAfter neutralization with aqueous NaHCO3, the crude product was extracted in ethyl acetate
- custompurified by preparative HPLC (0.034 g, 34% yield over 2 steps)
Quellen und Nachweise
- ORD-Eintrag
- ord-c003cbed967d4fa7b32b6ffacc50a4a9
- Quelldatensatz
- uspto-grants-2005_05
- Patentnummer
- US06897231B2
Notizen zur Reaktion
Wird geladen…